Burke M D, Whiting P H
Clin Nephrol. 1986;25 Suppl 1:S111-6.
In rats cyclosporine A (CsA) caused decreases in the hepatic microsomal P-450-dependent mono-oxygenase enzyme system and in glucuronyl transferase. The decrease in the mono-oxygenase was transient and may have been due to self-limiting suicide inactivation of P-450 by a CsA metabolite. Changes in hepatic mono-oxygenase activity over a period of 7 weeks were associated with a converse oscillation in CsA nephrotoxicity, indicating that CsA was detoxified by hepatic P-450. This impression was strengthened by observations that induction of P-450 by low-dose phenobarbitone led to decreases in both the circulating levels and nephrotoxicity of CsA, whereas cotreatment with the P-450 inhibitor ketoconazole caused increases in CsA circulating levels and nephrotoxicity. Induction by 3-methylcholanthrene had no effect. Cobaltous chloride, which suppresses the synthesis of P-450, exacerbated CsA nephrotoxicity. Neither cimetidine nor SKF-525A, both P-450 inhibitors, had any effect.
在大鼠中,环孢素A(CsA)导致肝微粒体中依赖细胞色素P-450的单加氧酶系统以及葡糖醛酸转移酶活性降低。单加氧酶活性的降低是短暂的,可能是由于CsA的一种代谢产物对细胞色素P-450进行了自限性自杀失活。在7周的时间里,肝单加氧酶活性的变化与CsA肾毒性的反向波动相关,这表明CsA可被肝细胞色素P-450解毒。低剂量苯巴比妥诱导细胞色素P-450可导致CsA的循环水平及肾毒性降低,而与细胞色素P-450抑制剂酮康唑联合治疗则导致CsA循环水平及肾毒性增加,这些观察结果进一步强化了上述观点。3-甲基胆蒽诱导细胞色素P-450无此作用。抑制细胞色素P-450合成的氯化钴会加剧CsA的肾毒性。两种细胞色素P-450抑制剂西咪替丁和SKF-525A均无此作用。